Study Boosts Fiber's Role in Colon Health

17 Jan 2014 --- Scientists have more reasons for you to eat fiber and not abuse antibiotics. They've shown that a receptor doctors already activate with mega-doses of niacin to protect patients' cardiovascular systems also plays a key role in preventing colon inflammation and cancer, according to a study featured on the cover of the journal Immunity.

The finding helps explain why a high-fiber diet reduces the risk of colon problems and indicates that when fiber is lacking, niacin, or vitamin B3, just may help keep the colon healthy as well, said Dr. Vadivel Ganapathy, Chairman of the Department of Biochemistry and Molecular Biology at the Medical College of Georgia at Georgia Regents University and a corresponding study author.

The study found that mice lacking the receptor, Gpr109a, were prone to inflammation and cancer of the colon, said Dr. Nagendra Singh, MCG immunologist, member of the Cancer Immunology, Inflammation and Tolerance Program at the GRU Cancer Center, and a corresponding study author.

And, when they gave niacin to mice whose healthy colonic bacteria had been wiped out by antibiotics – a frequent occurrence in chronic antibiotic use – it helped steer immune cells in the colon into a safe, anti-inflammatory mode.

Good bacteria in the colon thrive on fiber and its digestion produces butyrate, a short-chain fatty acid, which Ganapathy discovered years before naturally activates Gpr109a. However this relationship appears limited to the colon, where butyrate levels can soar in the face of a high-fiber diet.

Research teams at GlaxoSmithKline and the University of Heidelberg, Germany showed in 2003 that Gpr109a receptors on the surface of fat cells mediate the protective cardiovascular effect of niacin, including increasing good cholesterol, or HDL, while decreasing levels of disease-producing LDL. Their search for other activators identified butyrate, which led Ganapathy to find that not only is the Gpr109a receptor expressed on the surface of colon cells, but that with sufficient fiber intake, butyrate levels in the colon can activate it.

Now, he and Singh have shown activation of Gpr109a in the colon by butyrate prompts immune cells, which are in ample supply in that region, to suppress rather than promote inflammation, a factor in a number of painful conditions such as ulcerative colitis, Crohn's disease, and colorectal cancer.

Once butyrate activates the Gpr109a receptor on dendritic cells and macrophages in the colon, these immune cells start producing anti-inflammatory molecules and sending messages to the T cells, key orchestrators of immunity, to do the same, Singh said. Butyrate also prompts epithelial cells that line the colon to produce cytokines, which aid wound-healing, a critical step for resolving the intestinal inflammation that occurs in ulcerative colitis and Crohn's.

"To protect your colon, you need this receptor, as well as the fiber and butyrate which activate it," Ganapathy said. For people who won't or can't eat high-fiber diets, mega-doses of niacin, may help protect the colon, the way it's already protecting hearts, the scientists suggest.

"We think mega-doses of niacin may be useful in the treatment and/or prevention of ulcerative colitis, Crohn's disease, and colorectal cancer as well as familial adenomatous polyposis, or FAP, a genetic condition that causes polyps to develop throughout the gastrointestinal tract," Singh said. In fact, they've already shown that fiber depletion increases and mega-niacin doses decrease development of polyps in mice with FAP.

The colon and intestines are constantly exposed to foreign bacteria that enter the body primarily through the mouth. The good bacteria, which are essential to digestion and colon health, regularly communicate to immune cells that they are not the enemy and butyrate appears to be a key signal there as well, said Ganapathy, who also leads the Signaling and Angiogenesis Program at the GRU Cancer Center.

Next steps include pursuing clinical trials of niacin supplements in colon health and, potentially, epidemiological studies that examine intestinal inflammation and colon cancer rates in patients already taking niacin for cardiovascular health. The research was funded by the National Institutes of Health.

To contact our editorial team please email us at editorial@cnsmedia.com

Related Articles

Food Ingredients News

Yogurt culture: Danone North America launches low-fat Greek yogurt and almond milk yogurt alternative

18 Jan 2019 --- Danone North America has announced the launch of two individual yogurt lines that tap into both plant-based and sugar reduction trends. The first, coined Two Good Greek Lowfat Yogurt, is a dairy products line that touts indulgent taste, low calories and reduced sugar content. The second is Good Plants, a dairy-free, probiotic yogurt alternative, made with almond milk. Two Good will launch in February 2019, while Good Plants is already available.

Food Ingredients News

“Lighter formulation”: Fiber thrives amid fat, sugar and salt reduction strategies

15 Jan 2019 --- 2018 saw the introduction and expansion of regulatory pressures in the form of a sugar tax in the UK as the global obesity crisis worsens. In 2019, manufacturers and suppliers are expected to respond to these themes and seek to reduce overall levels of fat, sugar, salt and total calories in a clean and transparent way. The market has become so competitive that manufacturers need to keep their fingers on the consumer pulse. As a result, the notion of “lighter reformulation” has evolved alongside a renewed interest in fiber.

Food Ingredients News

Barley-derived polysaccharide holds diverse application potential

09 Jan 2019 --- A new complex carbohydrate in barley has been discovered by researchers at the University of Adelaide's School of Agriculture, Food and Wine in Australia. The cereal polysaccharide is the first of its kind to be discovered in 30 years and possibly holds potential in food, medicine and cosmetics applications.

Business News

PepsiCo start-up program: Israeli dairy alternative innovator secures top prize

09 Jan 2019 --- Israel-based start-up, Yofix, one of the ten finalists in PepsiCo’s European Nutrition Greenhouse program, has been awarded the final €100,000 grant (US$114,000) following a six-month journey. Yofix, which makes clean label plant-based fermented dairy alternatives impressed PepsiCo’s selection committee with its launch and retail growth during the program.

Food Ingredients News

2019 beverage trends: Bitter flavors, cold brew teas and probiotics are on the menu, says Treatt

09 Jan 2019 --- Sustainability, veganism and health are three macro trends that continue to dominate innovation in food and drink today. Treatt has uncovered how these macro trends will influence flavors and processes in the beverage category. The company has touted the trends that it believes are here to stay for 2019 and beyond, including cold brew teas and probiotic beverages, as consumers seek to support mental, physical and environmental health.

More Articles